Global Inhalers and Nebulizers Market Insights, Forecast to 2028
Market Analysis and Insights: Global Inhalers and Nebulizers Market
Due to the COVID-19 pandemic, the global Inhalers and Nebulizers market size is estimated to be worth US$ 14647 million in 2022 and is forecast to a readjusted size of US$ 18403 million by 2028 with a CAGR of 3.88% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Inhalers accounting for 92.09% of the Inhalers and Nebulizers global market in 2021, is projected to value US$ 16742 million by 2028, growing at a revised 3.69% CAGR from 2022 to 2028. While Asthma segment is altered to an 3.75% CAGR throughout this forecast period.
The global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Teva, Boehringer Ingelheim, Novartis, Organon, Omron, Philips, etc. In 2021, the global top five players hold a share approximately 76.61% in terms of revenue.
Global Inhalers and Nebulizers Scope and Segment
Inhalers and Nebulizers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inhalers and Nebulizers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.
By Company
GSK
AstraZeneca
Chiesi
Teva
Boehringer Ingelheim
Novartis
Organon
Omron
Philips
PARI GmbH
Yuwell
Drive DeVilbiss Healthcare
Leyi
Folee
Beurer
Segment by Type
Inhalers
Nebulizer
Segment by Application
Asthma
COPD
Others
Segment by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
South America
Brazil
Middle East & Africa
Middle East
Africa
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook